0001567619-18-006604.txt : 20181119 0001567619-18-006604.hdr.sgml : 20181119 20181119115319 ACCESSION NUMBER: 0001567619-18-006604 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20181119 DATE AS OF CHANGE: 20181119 EFFECTIVENESS DATE: 20181119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NextCure, Inc. CENTRAL INDEX KEY: 0001661059 IRS NUMBER: 475231247 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-326074 FILM NUMBER: 181191767 BUSINESS ADDRESS: STREET 1: 13503 SANDERLING PLACE CITY: GERMANTOWN STATE: MD ZIP: 20874 BUSINESS PHONE: 240-418-1773 MAIL ADDRESS: STREET 1: 13503 SANDERLING PLACE CITY: GERMANTOWN STATE: MD ZIP: 20874 D 1 primary_doc.xml X0708 D LIVE 0001661059 NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 240-399-4900 DELAWARE None None Corporation true 2015 Michael Richman c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Executive Officer Director President & Chief Executive Officer David Kabakoff c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Director Judith Li c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Director Stella Xu c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Director Michael Yi c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Director Steven Cobourn c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Executive Officer Chief Financial Officer Kevin N. Heller c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Executive Officer Chief Medical Officer Elaine Jones c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Director Chau Q. Khuong c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Director Tim Shannon c/o NextCure, Inc. 9000 Virginia Manor Road, Suite 200 Beltsville MD MARYLAND 20705 Director Biotechnology Decline to Disclose 06b false 2018-11-05 false true true true true Series B Preferred and Common Stock issuable upon the conversion thereof false 0 93432873 93432873 0 false 22 0 0 0 false NextCure, Inc. /s/Michael Richman Michael Richman President and Chief Executive Officer 2018-11-19